From Guangzhou to the World: How One Cancer Hospital Is Bringing Proton Therapy to South Asia

DHAKA, BANGLADESH — The 17th Janaka Medical Exhibition in Dhaka witnessed a milestone moment for China-South Asia cross-border healthcare collaboration. Among hundreds of exhibitors from around the world, one institution stood out as the only Chinese medical facility focused exclusively on advanced proton therapy: Guangzhou Concord Cancer Center (GCCC).

The exhibition booth, emblazoned with "South China's First Proton Center," drew crowds of Bangladeshi physicians, hospital administrators, and patients seeking answers to a single question: Can world-class cancer care be accessible and affordable beyond borders?

The Promise That Crosses Oceans

In Chinese culture, there is a concept called qiaopi (诚批) — letters sent by overseas Chinese to their families back home, carrying promises across oceans. Each letter represented a lifetime of trust and commitment.

A century later, that same spirit of commitment lives on. At the Dhaka exhibition, when South Asian colleagues asked about technology, doctor expertise, and cost competitiveness, GCCC answered not with marketing slogans but with a track record of delivered results:

• South China's first Proton Therapy system — Varian ProBeam precision technology
• Thousands of clinical cases led by nationally recognized experts
• Cure stories from real patients across Southeast Asia
• Treatment costs under half of comparable centers in Singapore or the West

"From the first encounter at an exhibition booth to deep partnerships and genuine praise from those who have experienced our care — our pursuit goes far beyond this moment."

Bringing World-Class Technology In

Guangzhou Concord Cancer Center's Proton Therapy System, featuring the internationally renowned Varian ProBeam, represents a breakthrough in precision oncology. Unlike conventional radiation, proton therapy delivers energy that stops precisely at the tumor site, sparing surrounding healthy tissue.

This is particularly critical for cancers in sensitive areas such as:

• Nasopharyngeal carcinoma — prevalent in Southern China and Southeast Asia
• Chordoma — rare tumors occurring near the spine and skull base (incidence ~1 in 1,000,000)
• Pediatric brain and spinal tumors — where minimizing long-term side effects is paramount
• Uveal melanoma and other ocular malignancies

Patient Story: Rafi's Journey from Indonesia

Rafi (pseudonym), an Indonesian man in his 30s, was diagnosed with a rare chordoma — a tumor so uncommon it affects only about one in a million people worldwide. After emergency surgery in Jakarta and unsuccessful treatment in Penang, Malaysia, he turned to Guangzhou Concord Cancer Center.

GCCC's expert team designed a comprehensive plan combining surgery followed by proton therapy:

1. Safe tumor removal by China's leading surgical oncology team
2. Post-operative proton radiotherapy to eliminate any residual cancer cells with sub-millimeter precision
3. Maximum preservation of neurological function throughout treatment
4. Systematic reduction of recurrence risk through integrated multidisciplinary care

The result? Rafi completed his proton treatment successfully. And the total cost? Less than half of what he would have paid in Singapore.

Going Out: From Exhibition to Strategic Partnership

Data from China's National Health Commission reveals the scale of opportunity:

Cross-border medical tourism is becoming a significant trend. And GCCC is positioning itself at the forefront of this movement.

Beyond the Booth: Building Trust Through Experience

To give international patients greater confidence, GCCC invited foreign guests to experience its health examination services firsthand. From efficiently completing multiple screening tests to one-on-one professional report interpretation by physicians, the experience speaks for itself.

"Medical services can actually be this comfortable." — International health check-up guest at GCCC

Looking Ahead: Sharing Expertise Along the Belt & Road

GCCC's ambitions extend far beyond receiving international patients. The hospital's forward-looking strategy includes:

• Exporting proton therapy technology — Actively promoting proton center construction projects in Southeast Asian countries
• Sharing mature oncology models — Transferring China's established cancer diagnosis and treatment protocols to partner institutions
• Building a cross-border medical cooperation community — Creating lasting partnerships among countries along the Belt and Road Initiative

Just as the qiaopi letters of old carried promises across oceans, Guangzhou Concord Cancer Center is now delivering a new kind of promise — one written not with ink, but with every accurate dose of proton radiation, every successful surgery, and every patient who returns home healthy.

---